When the clinical picture demands rapid saturation of the body with the active form of vitamin B12, high-dose injectable preparations move to the forefront. Methylcobalamin 2500 mcg, manufactured by India’s Shine Pro, is a concentrated ampoule solution tailored for a short yet potent course of parenteral therapy. The 5-ampoule pack is calibrated for an intensive initiation phase, after which the patient is either stepped down to a maintenance dose or transitioned to oral supplementation.
Methylcobalamin is not merely a vitamin; it is a preformed coenzyme form of B12 that enters metabolic pathways immediately upon reaching the bloodstream. The 2500 mcg strength — substantially surpassing standard prophylactic doses — is deployed in scenarios requiring:
This elevated dosage provides a more potent neuroprotective impulse: remyelination of damaged nerve fibers accelerates, levels of neurotoxic plasma homocysteine decline more rapidly, and normal bone marrow erythropoiesis is restored with greater speed.
Methylcobalamin injections at the 2500 mcg dose are prescribed for:
The product is a sterile injectable solution supplied in glass ampoules.
Methylcobalamin is traditionally characterized by low toxicity; nevertheless, the responsibility for therapeutic safety is shared between physician and patient:
Ampoules must be retained in their original packaging, shielded from direct sunlight. The permissible temperature ceiling is 25–30 °C (77–86 °F). Freezing the solution is inadmissible. The storage location must remain out of children’s reach.


